SIGHT SCIENCES, INC. Net Change in Cash
SIGHT SCIENCES, INC. (SGHT) reported Net Change in Cash of -$12.21 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-05
- SIGHT SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was -$7.00M.
- SIGHT SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$11.59M.
- SIGHT SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$10.85M.
- SIGHT SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$17.66M.
- SIGHT SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$28.13M.
- SIGHT SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$17.77M.
- SIGHT SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was -$46.87M.
- SIGHT SCIENCES, INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$75.69M, a 138.00% decline from fiscal 2021.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$12.21M 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | -$7.00M 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | -$28.13M 10-K · filed 2026-03-04 | |||
| 2025-09-30 | -$27.72M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | -$18.86M 10-Q · filed 2026-08-05 | |||
| 2025-03-31 | -$11.59M 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | -$17.77M 10-K · filed 2026-03-04 | |||
| 2024-09-30 | -$19.57M 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | -$19.95M 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | -$10.85M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$46.87M 10-K · filed 2025-03-07 | |||
| 2023-09-30 | -$40.50M 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | -$30.48M 10-Q · filed 2024-08-02 | |||
| 2023-03-31 | -$17.66M 10-Q · filed 2024-05-06 | |||
| 2022-12-31 | -$75.69M 10-K · filed 2024-03-13 | |||
| 2022-09-30 | -$60.87M 10-Q · filed 2023-11-07 | |||
| 2022-06-30 | -$40.59M 10-Q · filed 2023-08-07 | |||
| 2022-03-31 | -$22.10M 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | $199.18M 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $209.96M 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | -$25.94M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | -$13.18M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $40.27M 10-K · filed 2022-03-24 | |||
| 2020-09-30 | $5.61M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $14.51M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |